Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

3D imaging effectively tracks skin changes in vitiligo treatment.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Baricitinib shows promise for treating alopecia areata with mild side effects.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

New cytokine-targeted therapies show promise for treating alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.